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Abstract
Introduction Extracorporeal membrane oxygenation (ECMO) is 
a supportive cardiopulmonary bypass technique for babies with 
acute reversible cardiorespiratory failure. We assessed 
morbidity in ECMO survivors at the age of five years, when they 
start primary school and major decisions for their school careers 
must be made.
Methods Five-year-old neonatal venoarterial-ECMO survivors 
from the two designated ECMO centres in The Netherlands 
(Erasmus MC -  Sophia Children's Hospital in Rotterdam, and 
University Medical Center Nijmegen) were assessed within the 
framework of an extensive follow-up programme. The protocol 
included medical assessment, neuromotor assessment, and 
psychological assessment by means of parent and teacher 
questionnaires.
Results Seventeen of the 98 children included in the analysis 
(17%) were found to have neurological deficits. Six of those 17 
(6% of the total) showed major disability. Two of those six 
children had a chromosomal abnormality. Three were mentally
retarded and profoundly impaired. The sixth child had a right­
sided hemiplegia. These six children did not undergo 
neuromotor assessment. Twenty-four of the remaining 92 
children (26%) showed motor difficulties: 15% actually had a 
motor problem and 11% were at risk for this. Cognitive delay 
was identified in 11 children (14%). The mean IQ score was 
within the normal range (IQ =  100.5).
Conclusion Neonatal ECMO in The Netherlands was found to 
be associated with considerable morbidity at five years of age. It 
appeared feasible to have as many as 87% of survivors 
participate in follow-up assessment, due to cooperation 
between two centres and small travelling distances. Objective 
evaluation of the long-term morbidity associated with the 
application of this highly invasive technology in the immediate 
neonatal period requires an interdisciplinary follow-up 
programme with nationwide consensus on timing and actual 
testing protocol.
Introduction
Extracorporeal membrane oxygenation (ECMO) is a cardiopul­
monary bypass technique for providing life support in acute 
reversible cardiorespiratory failure when conventional man­
agement is not successful. Most patients receiving ECMO
support are neonates suffering from persistent pulmonary 
hypertension of the newborn, primary or secondary to meco­
nium aspiration syndrome, sepsis, or congenital diaphragmatic 
hernia. Worldwide, over 18,700 neonates have been treated
CDH =  congenital diaphragmatic hernia; ECMO =  extracorporeal membrane oxygenation; IQ =  intelligence quotient; M-ABC =  Movement Assess­
ment Battery for Children; RAKIT =  Revised Amsterdam Intelligence Test; SD =  standard deviation.
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with ECMO for respiratory problems, and the overall survival 
rate was 77% [1].
The UK Collaborative ECMO Trial Group in 1996 presented 
the results of a randomised controlled clinical trial, showing a 
significant survival benefit of ECMO, without a concomitant 
rise in severe disability at one year of age [2,3]. Even for the 
35 neonates with congenital diaphragmatic hernia (CDH) the 
risk of death was reduced (relative risk, 0.72; 95% confidence 
interval, 0 .54-0 .06 ; P  =  0.03). O f the 18 neonates with CDH 
allocated to ECMO, however, 14 died (one after discharge) 
and only three children survived to age 4 years. All 17 infants 
in the conventional management arm died before discharge 
[4]. No other therapeutic intervention (that is to say, high-fre­
quency oscillatory ventilation, surfactant, and inhaled nitric 
oxide) for neonatal acute respiratory failure has such a positive 
impact on mortality and morbidity [5].
Nevertheless, the severity of illness of potential candidates for 
ECMO, as well as the risks associated with the procedure 
itself, places the ECMO survivor at high risk of developing 
brain injury and subsequent function deficits. All patients 
receiving ECMO support have suffered from severe respira­
tory failure prior to treatment. Prolonged episodes of severe 
hypoxaemia may occur, despite the administration of 100% 
oxygen. The inevitable high ventilatory pressures and hyper­
ventilation may cause alterations in cerebral blood flow [6,7]. 
In venoarterial ECMO the right common carotid artery and 
right internal jugular vein are cannulated and subsequently 
ligated after bypass is finished. Finally, the heparin that is 
administered to prevent the blood from clotting might cause 
intracranial haemorrhage as a confounder for long-term mor­
bidity. It is not easy, therefore, to predict the long-term out­
come of neonates treated with ECMO.
The few reports on structural follow-up of ECMO survivors 
either describe infants up to age 2 or patients from a single 
centre with wide age distribution [3,8-15]. The reports point 
out that logistic problems may prevent patients from being 
available for predetermined, structural evaluation. Major disa­
bilities in terms of severe developmental delay or neuromotor 
disabilities were reported in some 20% of ECMO survivors 
[3,8,10,12]. The range of morbidity widens with evaluation 
after age one, when assessment of cognitive skills, coordina­
tion, behavioural difficulties, and sensory loss can be more pre­
cise [16]. Long-term longitudinal follow-up of these children 
therefore seems essential for placing ECMO results in per­
spective. Only two studies describe longitudinal neurodevel- 
opmental evaluation at school age [1 6,17]. Although surviving 
children treated for severe life-threatening respiratory failure 
soon after birth show considerable long-term morbidity, the 
results of the UK ECMO trial point to a favourable profile of 
long-term morbidity in the group assigned to ECMO [16].
Glass and colleagues reported a 61% response rate; 25% did 
not participate because of the long travelling distances in the 
USA [1 7]. Neonatal ECMO in The Netherlands is provided in 
two designated centres only, authorised by the Dutch govern­
ment. All parents of ECMO survivors are invited to enter their 
child into a redesigned follow-up programme. High response 
rates are feasible because travelling distances are short in The 
Netherlands and regionalised high-risk perinatal care, includ­
ing ECMO, is available. The children are scheduled to undergo 
assessment at ages 6, 12, 18 and 24 months and 5, 8 and 12 
years. In the present paper we present the follow-up findings 
at age 5 years, when children are in the first year or second 
year of primary school and major decisions for their future 
school careers must be made.
Materials and methods
Patients
The study population included five-year-old neonatal venoarte­
rial ECMO survivors from both ECMO centres in The Nether­
lands (the Erasmus MC -  Sophia Children's Hospital 
Rotterdam and University Medical Center Nijmegen). The 
patients were seen either between May 2001 and December 
2003 (Rotterdam) or between March 1998 and December 
2003 (Nijmegen). According to national consensus on neona­
tal follow-up and the obligation to provide these data based on 
reports of the Dutch Ministry of Health, the assessment proto­
col is the standard of care in The Netherlands following 
ECMO. As a consequence IRB approval was waived, while all 
parents were routinely informed about the long-term follow-up 
programme in the neonatal period of life of their child.
Assessment protocol
Complete assessment included a one hour medical assess­
ment by a paediatrician/neonatologist experienced in the fo l­
low-up evaluation, a 1.5-hour neuromotor assessment by a 
paediatric physiotherapist, and a three hour neuropsychologi­
cal assessment by a psychologist or psychological test assist­
ant (Table 1). In Nijmegen a speech therapist assessed 
speech and language development, and in Rotterdam the psy­
chologist performed the neuropsychological assessment.
The complete assessment took place in one day. The 
sequence of the different assessments could vary for logistic 
reasons.
In addition, one month before assessment, the parents were 
invited to complete questionnaires on parental socio-eco­
nomic status and the child's current general health and 
behaviour.
Perinatal characteristics such as birthweight, gestational age, 
age at start of ECMO, duration of ECMO, primary diagnosis, 
and possible intracranial abnormalities were obtained from 
each centre's ECMO registry and are included in the Extracor- 
poreal Life Support Organisation Registry Report [1].
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Table 1
Assessment protocol at 5 years of age
Time (hours) Instrument Nijmegen Rotterdam
Medical assessment (paediatrician) 1 Physical and neurological examination X X
Neuromotor assessment (paediatric 
physiotherapist)
1.5 Movement Assessment Battery for Children 
Exercise test
X X
X
Neuropsychological assessment 
(psychologist and speech therapist)
3
Intelligence Revised Amsterdam Intelligence Test/ 
Wechsler Intelligence Scale for Children
X X
Visual -  motor integration Beery X
Receptive language development Reynell X X
Expressive language development Schlichting X X
Behaviour Child Behaviour Checklist/Teacher's Report 
Form
X X
Medical assessment
Medical assessment consisted of taking the child's medical 
history, the measurement of growth parameters, and a stand­
ard physical examination followed by a standard neurological 
examination. The length and weight were expressed as the 
standard deviation (SD) score using the Dutch Growth Ana­
lyser, version 2.0 (Dutch Growth Foundation, Rotterdam, 
Netherlands). The results of the neurological examination were 
categorised into normal (no neurological abnormalities), minor 
neurological dysfunction (neurological abnormalities without 
influence on normal posture or movement), and major neuro­
logical dysfunction (neurological abnormalities with abnormal 
posture or movements, including seizure disorders).
Neuromotor assessment
The Movement Assessment Battery for Children (M-ABC) was 
used to measure motor functioning [18]. A Dutch standardisa­
tion study has shown that the original norm scores and cut off 
points can also be applied to Dutch children. Good validity 
and reliability have been demonstrated [18,19].
The M-ABC was developed for children aged 4 -1 2  years. The 
measure has four age-related item sets, each consisting of 
eight items: three manual dexterity items (a time-related task 
for each hand separately, a bimanual coordination task, and a 
graphical task with the preferred hand), two ball skill items (a 
task of catching a moving object and a task of aiming at a 
goal), and three balance items (static balance, dynamic bal­
ance while moving fast, and dynamic balance while moving 
slowly). Scores may range from 0 to 5 for each item. A high 
score on the M-ABC indicates poor performance. The total 
impairment score, which is the sum of the item scores, was 
calculated as a percentile score. A score below the 5th per­
centile is indicative of a motor problem, a score between the
5th and 15th percentile means borderline performance, and a 
score above the 15th percentile is a normal score [18].
Exercise test
The children seen in Rotterdam performed a graded, maximum 
exercise test using a motor-driven treadmill. The treadmill was 
programmed for increases in angle of inclination and speed 
every three minutes according to the Bruce protocol [20,21]. 
The Bruce protocol starts with a speed of 2.7 km/hour at an 
incline of 10%. The children are encouraged to perform to vol­
untary exhaustion. The maximal endurance time was used as 
criterion of exercise capacity and compared with data 
reported previously [21,22].
Neuropsychological assessment 
Cognitive development
A short version of the Revised Amsterdam Intelligence Test 
(RAKIT) for children was used to evaluate cognitive develop­
ment. The RAKIT is a well-known standardised instrument in 
The Netherlands for children aged 4-11 years. Good reliability 
and validity have been demonstrated [23,24]. The short ver­
sion contains six subtests. The raw subtest scores are con­
verted into standardised scores, which are then transformed 
into a short RAKIT intelligence quotient (IQ) with a mean of 
100 and a SD of 15. Cognitive delay was defined by a test 
result more than -1 SD below the norm (that is to say, IQ < 85).
Visual-m otor integration
The Developmental Test of Visual-Motor Integration for chil­
dren aged from 3 to 18 years measures the integration of vis­
ual perceptual and motor abilities [25]. Children are asked to 
copy figures of increasing geometric complexity. The com­
puted raw item scores are transformed into a visual-motor 
integration standard score with a mean of 100 and a SD of 15.
Page 3 of 11
(page num ber no t for c ita tion  purposes)
Critical Care Vol 10 No 5 Hanekamp et al.
Figure 1
144
neonates received VA-ECMO support between 
January 1996 and December 1998
31 infants 
died
113 infants eligible for 
follow-up
2 unknown residence
3 moved to abroad 
6 no consent
4 unknown reason
98 infants participated in 
follow-up program
Flowsheet of infants included in the follow-up programme. VA-EMCO, 
venoarterial extracorporeal membrane oxygenation.
Behaviour
The Dutch versions of the Child Behaviour Checklist and the 
Teacher's Report Form were completed by parents and teach­
ers, respectively [26,27]. Both have been standardised for the 
Dutch population from 4 to 18 years old, and rate 120 problem 
behaviour items on a three-point scale (0 =  not true, 1 =  some­
what true or sometimes true, 2 =  very true or often true) 
[28,29]. A total problem score is computed by summing the 
scores of all items. Two broadband scales were constructed: 
an internalising scale including withdrawn behaviour, somatic 
complaints without physical cause, and anxious-depressive 
feelings; and an externalising scale including aggressive and 
delinquent behaviour. Total scores >60 classify children in the 
borderline/clinical range.
Language development
Language development was assessed with the Reynell Test 
and the Schlichting Test. The Reynell test assesses receptive 
language development of Dutch-speaking children between 
ages 1 and 6 years [30]. Expressive language is not required 
since the children may respond nonverbally.
The Schlichting Test assesses language expression of Dutch­
speaking children between ages 1 and 6 years [31]. Two sub­
tests were applied: one testing knowledge of grammatical 
structure (syntactical development), and the other subtest 
measuring active vocabulary (lexical development).
The numbers of correct answers in the tests were transformed 
into standard quotient scores with a mean of 100 and a SD of 
15. The following categories were discerned: delayed/abnor­
mal development (score less than -2 SD), at risk (score from - 
1 SD to -2 SD), and normal (score greater than -1 SD).
Data analysis
Data are presented for the entire group and also by diagnosis. 
An independent-sample Student t test was performed when 
appropriate to analyse differences between the study group 
and general population norms. P  <  0.05 represented statisti­
cal significance.
A chi-square test was performed to test whether the motor 
performance scores in this ECMO population differed signifi­
cantly from the distribution in the normal population. P  <  0.05 
was considered statistically significant.
Results
A total of 144 neonates received venoarterial-ECMO support 
from January 1996 up to and including December 1998. 
Thirty-one of them (22%) died before age 5 years, all during 
first admission at median age 21 days (interquartile range, 11­
35 days; range, 2 -1 2 0  days). Fourteen infants were lost to fo l­
low-up for various reasons. The present addresses of two chil­
dren could not be traced, the families of three children moved 
abroad, and parental consent was withheld for five children. 
Four other children failed to appear, even after repeated invita­
tions. Ninety-nine infants therefore participated in the follow- 
up programme (Figure 1). The parents of one child, however, 
withheld consent to use data for publication purposes, so 
eventually we present data of 98 children (35 children in Rot­
terdam, 63 children in Nijmegen) (87% of all survivors).
The perinatal characteristics and ECMO-treatment character­
istics of the participants are presented in Table 2. The 
children's basic characteristics at time of follow-up are pre­
sented in Table 3.
Outcome medical assessment
Seventeen children (17%) were found to have a neurological 
disorder. Six of those (6%) showed major neurodevelopmental 
disability, including two children with a chromosomal abnor­
mality. Of the latter, one child was known to have Down syn­
drome and the second child (diagnosed with CDH) showed 
unbalanced translocation of chromosome 11 -22  (unknown at 
the time of ECMO). This boy was severely impaired and men­
tally retarded, and is known to have died at age six years.
Of the other four children with major neurological disorder, 
one had a right-sided hemiplegia caused by nonhaemorrhagic 
infarction during ECMO. He walked with an orthesis and 
attended special education. The second child had developed 
a right-sided hemiplegia as a result of left-sided cerebral hemi­
atrophy. He was confined to a wheelchair and was mentally 
retarded. The third child with major neurological disorder 
(diagnosed with meconium aspiration syndrome) had severe 
asphyxia and had been resuscitated in the immediate postna-
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Table 2
Perinatal and extracorporeal membrane oxygenation (ECMO) characteristics
Male/female 60/38
Birthweight (kg) 3.3 (2.9-3.8)
Gestational age (weeks) 40 (38-41)
Apgar score at 1 minute/5 minutes 
Primary diagnosis
5/7
Meconium aspiration syndrome 51
Congenital diaphragmatic hernia 20
Sepsis 11
Persistent pulmonary hypertension of the newborn 15
Congenital cystic adenoid malformation of the lung 
Outborn (n)
1
Home 10
>20 km from ECMO centre 51
<20 km from ECMO centre 30
Oxygenation index prior to ECMOa 39 (24-58)
Alveolar arterial oxygen distention gradientb 622 (606-637)
Age at start of ECMO (hours) 28 (17-43)
Duration of ECMO support (hours) 155 (127-188)
Duration of mechanical ventilation (days) 16 (13-22)
Supplemental oxygen after ECMO (days) 8 (4-16)
Duration of first admission (days) 
Haemorrhagic intracranial abnormalities (n)
38 (30-55)
Minor: intraventricular haemorrhage grade 1 and grade 2 8
Major: intraventricular haemorrhage grade 3 and grade 4 
Nonhaemorrhagic intracranial abnormalities (n)
0
Minor: ventricular dilatation and focal atrophy 17
Major: general atrophy and infarcts 4
Observed infants with epileptic insults (n) 27
Patients treated with phenobarbital as prophylaxis (n) 37
Duration of phenobarbital treatment in infants with epileptic insults (days) 49 (21-90)
Perinatal characteristics of the 98 children available for analysis, presented as n (%) of infants or median (interquartile range). aCalculated as
[(mean airway pressure x FiO2)/PaO2] x 100. bCalculated as Patm -  PH2O ■-  PaO2 -  PaCO2 (PaO2 and PaCO2 in mmHg).
tal period. Still suffering from a seizure disorder, she used a The mean (SD score) weight and height for the entire popula­
walking frame, and she was mentally retarded. The fourth child tion were -0.5 (1.5) and -0.4 (1.2), respectively (Table 3). Both
suffered from seizures, used a wheelchair, and was mentally parameters were significantly below zero (P =  0.001 and P  =
retarded. 0.002, respectively).
Eleven children (11%) showed minor neurological dysfunc- Eighteen children (18%) had respiratory complaints. Twelve of
tion, varying from strength differences in the upper and lower them regularly used a combination of p-sympathicomimetic
extremities to very mild hemiplegia and a mild form of W est drugs and inhalation steroids. None of the children needed
syndrome (one child). supplemental oxygen. Two of the total population were fol­
lowed because of a muscular ventricular septal defect, without
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Table 3
Basic characteristics o f the study group at 5 years o f age
Total group (n =  98)
Males/females 
Age (months)
Weight SD score 
Height SD score 
Weight for height SD score 
Socioeconomic status (%) 
High 
Normal 
Low
Unknown 
Ethnic group (%)
White
African
Asian
Turkish or Moroccan
60/38 
62 (3.0) 
-0.5 (1.5)* 
-0.4 (1.2)** 
-0.4 (1.4)**
26 (27) 
49 (50) 
19 (19)
4 (4)
85 (87)
3 (3)
1  (1 )
9 (9)
Data presented as n (%) of patients or mean (standard deviation (SD)). The mean weight, height and weight for height (SD scores) for the entire 
population were all significantly below zero: * P =  0.001, ** P =  0.002, *** P =  0.008. Children with congenital diaphragmatic hernia had 
significantly lower height and weight than children with meconium aspiration syndrome (P <  0.001).
Table 4
MovementAssessment Battery fo r Children results
Total g roup  (n =  92) M econium  aspiration 
syndrom e (n =  49)
C ongen ita l d iaphragm atic 
hernia (n =  19)
Sepsis (n =  11) P ersisten t pulm onary hypertension 
o f the new born (n =  12)
Total im pairm ent score  (mean 
(standard deviation))
8.4 (8.1)* 6.8 (6.6) 13.4 (10.3) 7.5 (7.5) 7 (7.1)
Sco re  <  P 5, m otor problem  (n (%)) 14 (15 .2% )** 3 (6.1) 7 (36.8) 1 (9.1) 2 (16.7)
Sco re  P 5 - P  15, borderline (n (%)) 10 (10.9% ) 3 (6.1) 4 (21.1) 2 (18.2) 1 (8.3)
Sco re  >  P 1 5 , normal (n (%)) 68  (73 .9% )*** 4 3  (87.8) 8 (42.1) 8 (72.7) 9 (75)
*t test: significant, P <  0.001. ** Chi-square test: significant, P <  0.001. ***Chi-square test: significant, P <  0.005.
haemodynamic consequences; one because of atrial septal 
defect. One of the 20 children diagnosed w ith CDH was still 
on (nightly) tube feeding because of low w eight (-3.4 SD) and 
pulmonary problems, and a second child had received tube 
feeding until his fourth birthday. The child who was known with 
unbalanced translocation of chromosome 1 1 -2 2  was fed 
through a gastrostom y drain and had undergone a Nissen fun­
doplication because of gastrooesophageal reflux. Another 
child, not diagnosed w ith CDH, was also fed through a gas­
trostom y drain.
Outcome neuromotor assessment
Excluding the six children w ith major neurodevelopmental d is­
ability, 92  of the 98 children were tested using the M-ABC. 
Twenty-four children (26.1% ) were classified as having some
kind of m otor d ifficu lty (percentile score <  P 15), which repre­
sents a significantly higher proportion than expected (chi- 
square test, P  <  0.005).
Fourteen children (15.2% ) had scores indicative of a motor 
problem (percentile score <  P 5) (chi-square test, P  <  0.001), 
10 children (10.9% ) had borderline performance (percentile 
score <  P 15 but >  P 5), and 68 children (73.9% ) performed 
normally (percentile score >  P 15) (Table 4 ).
A  comparison w ith population norms revealed that the mean 
(SD) M -ABC  score of the total group was significantly below 
the reference value: 8 .4 (8.1) versus 5.2 (5.6) (P  <  0.001) 
[18].
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Table 5
Exercise test
Total group (n =  29) Boys (n =  15) Girls (n =  14)
Endurance time (minutes) (mean (standard deviation)) 9.0 (1.2)* 9.2 (1.8)
Less than -2 SD, abnormal (n (%)) 1 (3.4%) 0 1
-1 SD to -2 SD, suspect (n (%)) 8  (27.6%) 7 1
Greater than -1 SD, normal (n (%)) 20 (69.0%) 8 1 2
Score according to Cumming and colleagues [21]. *t test: significant, P <  0.001.
Table 6
Neuropsychological outcome
Total group (n =  82)
Intelligence quotient (n =  79) 100.5 (19.7)
70-85 4 (5.1%)
51-70 3 (3.9%)
<50 4 (5.1%)
Expressive language (n =  78)
Grammar 104.2a (17.9)
70-85 11 (14.1%)
51-70 2  (2 .6 %)
<50 --
Vocabulary 103.2 (19.6)
70-85 6  (7.8%)
51-70 5 (6.5%)
<50 2  (2 .6 %)
Receptive language (n =  81) 104.3a (15.3)
70-85 1  (1 .2 %)
51-70 5 (6.1%)
<50 --
Visual -  motor integration (n =  28) 96.6 (13.7)
70-85 7 (25%)
51-70 --
<50 --
Data presented as the mean (standard deviation) or as n (% of total number). aSignificant difference (P <  0.05) from the Dutch population norm.
Twenty-nine of the 35 children seen in Rotterdam performed 
the exercise test according to the Bruce pro tocol (Table 5 ). 
Five children w ith major neurological impairment could not 
perform the test. One child (diagnosed w ith CDH) was too 
anxious to use the treadmill and performed a six-minute walk­
ing test instead. The height and w eight of the 29 children (15 
boys) were expressed as SD scores. These were not sign ifi­
cantly below or above the reference value (SD =  0) and there 
were no significant differences between boys and girls. C om ­
parison of endurance times w ith the Canadian norms reported
by Cumming and colleagues [21] revealed a significantly 
lower mean (SD) endurance time fo r the boys: 9.0 (1.2) versus 
10.4 (1.9) (P  <  0.005). The mean endurance time for the girls 
was not significantly different: 9.2 (1.8) versus 9.5 (1.8) (P  =  
0.6).
Outcome neuropsychological assessment
To create a mutually comparable group, three children with 
chromosomal or syndromal abnormalities as well as 11 chil­
dren who did not speak Dutch as their native language and
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Table 7
Child Behaviour Checklist (n =  86)
Total problem score
<60 72 (83.5%)
60-63 5 (5.9%)
>63 9 (10.5%)
Internal problem score
<60 72 (83.7%)
60-63 7 (8.1%)
>63 7 (8.1%)
External problem score
<60 76 (88.4%)
60-63 6  (7.0%)
>63 4 (4.7%)
Data presented as number of patients (%). The internal scale includes withdrawn behaviour, somatic complaints without physical cause, and 
anxious-depressive feelings. The external scale includes aggressive and delinquent behaviour. Scores >60 but <63 are in the borderline range. 
Scores >63 are in the clinical range.
one child w ith severe hearing problem s were excluded from 
data analysis. One child 's data on all neuropsychological tests 
were lost, leaving 82 children fo r analysis. For three children all 
data on cognitive developm ent were missing. Three children 
could not be successfully tested on expressive language, and 
one child could not be tested either on expressive or on recep­
tive language. V isua l-m otor integration in Rotterdam was 
tested in 28 out of 35  children. Major neurological impairment 
precluded testing in five children and the data of two other 
children were missing. The neuropsychological outcom e data 
are presented in Table 6.
Cognitive development
Eleven children (14.1% ) showed cognitive delay. The mean 
RAKIT score of the total group (IQ =  100.5) did not differ s ig ­
nificantly from the Dutch norm.
Language development
In the expressive language test, 13 children (16.7% ) scored > 
1 SD below  the norm on grammar and vocabulary. In the 
receptive language test, six children (7.3% ) scored > 1 SD 
below  the norm. The mean scores on grammar and receptive 
language were significantly above the Dutch norm.
Visual-m otor integration
Seven children (25% ) scored > 1 SD below  the norm. The 
mean score of the total group did not differ significantly from 
the Dutch norm.
Behaviour
The results of the Child Behaviour Checklist are presented in 
Table 7. O f all children, 12.8%  had a total problem score
above 63, indicating behavioural problems. Internalising p rob­
lems occurred slightly more than did externalising problems.
Discussion
The present report presents nationwide neurodevelopmental 
sequelae of 98  venoarterial-ECM O-treated neonates at age 5 
years (87%  of all survivors). Seventeen children (17% ) pre­
sented w ith major or minor neurological disorders. Another 24 
children (26.1% ) of the children who participated in the neu­
rom otor assessment presented w ith some kind of m otor d iffi­
culty, 14 of whom (15.2% ) had an actual m otor problem and 
10 of whom (10.9% ) were at risk for a m otor problem. C ogn i­
tive delays were identified in 11 children (14%  of 82 analysed 
children).
Two of the 17 children w ith neurological disability had a chro­
mosomal d isorder accounting for neurological impairment, 
and one child had W est syndrome associated w ith mental 
retardation and seizures. Four of the remaining 14 patients 
(14% ) had major neurological impairment and 10 children had 
m inor neurological impairment w ithout an underlying disorder. 
O ur find ings seem not com pletely consistent w ith findings 
reported by G lass and colleagues [17] in 103 children: 17%  
of children in that study had one or more major disability versus 
14%  in our group. G lass and colleagues, however, ranked 
mental disability, as well as m otor disability and seizure d isor­
ders, also under major disability. Had we included children 
who scored abnormal in the medical assessment, motor 
assessment, or mental assessment as well, we would have 
found a sim ilar proportion (17%).
The UK ECM O  Trial G roup has reported on the outcom e of 
ECM O -treated neonates at age 4 years [1 6]. A  consistent
Page 8 of 11
(page num ber no t fo r c ita tion  purposes)
Available online http://ccforum.com/content/10/5/R127
comparison is hampered by the fact that m ethods were differ­
ent. In the United Kingdom one paediatrician assessed the 
children in six clinical domains, including cognitive ability, neu­
romotor skills, general health, behaviour, vision, and hearing. 
Nineteen per cent of the children had test scores outside the 
normal range. W ith  regard to 'disability', 13%  of the children 
were moderately to severely disabled, which is consistent w ith 
the 14%  we report.
The rate of m otor difficu lties in our cohort was 26%  (score <  
P 15); 15%  of the children had an abnormal m otor score 
(score <  P 5). This 15%  we found exceeds the 6%  reported 
by G lass and colleagues [1 7]. Unfortunately, few  follow-up 
studies have used standardised tests such as the M -ABC  to 
assess neurom otor outcome. Even in our study some of the 
children w ith minor m otor difficu lties were assessed normal at 
neurological examination. In the M -ABC  assessment, however, 
the children are stressed to move under velocity or accuracy 
demands. Such circum stances are more sensitive to detect 
motor performance problems. It is essential, therefore, that 
professionals w ith specific  experience should assess the 
developmental domains in the context of a structured follow- 
up programme.
In our study 29 children performed a maximum exercise test. 
The maximal endurance time was used as the criterion of exer­
cise capacity, and we com pared outcom es w ith the data pre­
sented by Cumming and colleagues [21]. Binkhorst and 
colleagues in 1992 published references values for normal 
exercise performance in Dutch boys and girls aged 4 -1 8  
years using the Bruce treadmill pro tocol [22]. The authors 
included few 4 year olds and the number of 6 year olds is 
unclear, however, and they did not provide means and SDs for 
these ages. This is why we did not use these Dutch reference 
values. Nevertheless, 41%  of the children in our study would 
score below the 5th percentile according to these Dutch ref­
erence values. The question is whether this can be explained 
by impaired physical condition of ECM O -treated patients or by 
the fact that the reference values established by B inkhorst and 
colleagues insufficiently reflect the exercise performance of 
contemporary healthy Dutch children. Future studies are 
needed and will be performed in Erasmus M C -  Sophia C h il­
dren's Hospital in the near future.
Follow-up at age 5 is important because children are in their 
first year or second year of primary school, at the start of their 
further school career. Eleven children (14% ) showed cognitive 
delay, a proportion com parable w ith that reported by G lass 
and colleagues (13% ). The IQ  summary scores are com para­
ble as well: 100 in our cohort versus 96 in their study. 
A lthough in the UK ECM O  trial cognitive ability at age 4 did not 
show  evidence of a difference between the two trial groups, 
23%  of ECM O -treated children showed cognitive delay 
(defined as IQ  greater than -1 SD) [16].
Behavioural problem s beyond the clinical cuto ff point were 
identified in 11 children in our cohort. These problem s might 
contribute to school failure, even in the absence of cognitive 
delay [32].
Language development scores were all above population 
norms. Children w ithout Dutch as their native language who 
had difficu lty understanding and speaking Dutch were, how­
ever, excluded from these tests. Still, language development 
seems unaffected.
In the absence of a matched contro l group it remains difficu lt 
to establish to what extent ECM O  treatm ent contributes to the 
outcome. The UK ECM O trial did show  a benefit of ECMO 
based on the primary outcom e of death or severe disability. 
Children were assessed at age 4 in six d ifferent domains (cog­
nitive ability, neuromotor skills, general health, behaviour, 
vision, and hearing). The trial defined outcom e as normal, 
impaired, or disabled on the basis of the degree of functional 
loss in any of the domains. There was no evidence of s ignifi­
cant difference regarding cognitive ability and m otor disability 
between the conventional treatm ent and ECM O groups. The 
overall rate of moderate disability in the conventional group 
was 11%  versus 13%  in the ECM O group. Severe disability 
was only reported in the ECM O  group (that is to say, 3% ) [16]. 
The rate of disability (that is to say, cerebral palsy) reported in 
a study of 89 surviving children w ith moderate to severe peri­
natal asphyxia at age 8 years was 15%. Ten per cent of chil­
dren had profound cognitive delay [33]. The intelligence 
quotient in a group of nondisabled children w ith mild and m od­
erate perinatal asphyxia was 106 (±  14) [33]. These propor­
tions are in the same range as the proportions reported in the 
present study.
S ince all infants received venoarterial ECMO, would veno- 
venous ECM O  improve cognitive or neurom otor outcom e? 
W hen using the Extracorporeal Life Support Organisation 
Registry [1], no significant difference in primary outcome 
between venovenous ECM O and venoarterial ECM O has 
been reported [34].
Conclusion
The outcom e figures of ECM O -treated neonates at follow-up 
at age 5 years presented in the present study show  consider­
able morbidity, but they do not greatly differ from those 
reported in previous publications on ECM O -treated neonates 
[16,1 7]. The high response rate of 87%  (versus 61%  by Glass 
and colleagues [17]) was feasible fo r various reasons: coop­
eration between tw o centres, small travelling distances, as 
well as the quality of the health care system in The Nether­
lands. W e believe that a successful fo llow-up programme of 
severely ill neonates should be structured in consultation with 
representatives from different disciplines, such as a paediatri­
cian, a paediatric physiotherapist, a psychologist, and a 
speech therapist. Further longitudinal follow-up studies will
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focus on the relationship between neonatal status and test 
results at 5 years and on detailed analysis of the different 
domains. W ith in  the fram ework of the nationwide follow-up 
programme, longitudinal data at ages 8 and 1 2 years are 
expected to become available in due time.
Key messages
• Follow-up after neonatal venoarterial ECM O  in children 
at age 5 showed 17%  of children w ith major or minor 
neurological disorders and 26%  w ith some kind of 
m otor difficulty.
• Cognitive delay was present in 14%  of the 5-year-old 
children after neonatal venoarterial ECMO.
• A  successful fo llow-up programme of severely ill 
neonates should be structured in consultation w ith rep­
resentatives from different disciplines.
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